The CEEHRC Pod

Dr. Federico Gaiti is a scientist at Princess Margaret Cancer Center and Assistant Professor at the University of Toronto. In this episode, he shares his career path and his current research on how epigenetics shapes brain cancer biology.

Dr. Martin Hirst is Head of Epigenomics at Canada’s Michael Smith Genome Sciences Centre, Director of the Michael Smith Laboratory and Professor at the University of British Columbia.  This interview, co-hosted by Alvin Qiu and Benjamin Lebeau, focuses on Dr. Hirst’s career and future perspectives on epigenetic approaches for cancer therapy. 

In this special episode of the CEEHRC podcast, students and professors share their research, experiences, and highlights from the Annual CEEHRC Conference, offering perspectives from different stages of an academic career.

Dans cet épisode hors-série du podcast du CEEHRC, nous recevons Dr. Émilie Dubois, directrice d’Impackt Scientifique. Elle partage son parcours et sa vision du rôle de la communication et de la valorisation scientifique, en mettant en lumière les liens entre recherche, impact sociétal et diffusion des connaissances. Un échange inspirant pour mieux comprendre les enjeux de la science au-delà du laboratoire.

Dr. Rafaela Andrade is the Co-founder and CEO of Myomar Molecular, a Canadian biotechnology company at the forefront of muscle health monitoring. Rafaela’s scientific journey began at Dalhousie University, where she earned her PhD in the laboratory of Dr. Paola Marignani, focusing on the intersection of cancer and metabolism. Her transition from the bench to industry accelerated during her postdoctoral studies at the Creative Destruction Lab (CDL), where she was recognized nationally as a leading female biotech founder. It was there that she pioneered the technology behind Myomar, which utilizes molecular biomarkers to monitor and predict muscle health. In recognition of her impact on the industry, she was named the 2023 Outstanding Entrepreneur of the Year.